Yohei Tomita

Yohei Tomita

Department of Ophthalmology, Boston Children's Hospital, Harvard Medical School

Affiliated withBoston Children's Hospital, Harvard Medical SchoolHarvard Medical School

Research Area

Biography

Yohei Tomita is a senior staff scientist at the ophthalmology department in Boston Children’s Hospital and a visiting instructor at the ophthalmology department in Keio University School of Medicine.

Dr. Tomita graduated in medicine from Shimane University in Japan. He completed his ophthalmology residency, retinal fellowship, and earned his Ph.D. at Keio University School of Medicine. Then he joined at Ophthalmology department at Harvard Medical School, Boston Children’s Hospital as a research fellow. He is the recipient of the Bert M. Glaser, MD Award for Innovative Research in Retina (2021), the Young Investigator Award (2020) in Japan Ophthalmology Society, and the Young Investigator Grant Award (2020) in Alcon Research Institute. He is also a review editor and a guest editor for several journals.

Dr. Tomita is also now developing a new instrument that can measure mitochondrial function in the retina in vivo using Raman spectroscopy as well as a similar instrument using microfluidics and Raman to interrogate mitochondrial function.

JoVE Journal Publications

ArticleTotal : 2
Year
Endothelial Cell Transcytosis Assay as an <em>In Vitro</em> Model to Evaluate Inner Blood-Retinal Barrier Permeability
Publication title

Cited by 6

2022
2020

Other Publications

Article
Year
Dyslipidemia in retinal metabolic disorders.

EMBO molecular medicine| PubMed ID: 31486227

2019
Long-Acting FGF21 Inhibits Retinal Vascular Leakage in In Vivo and In Vitro Models.

International journal of molecular sciences| PubMed ID: 32054022

2020
Targeting Neurovascular Interaction in Retinal Disorders.

International journal of molecular sciences| PubMed ID: 32098361

2020
2020
Pemafibrate Protects Against Retinal Dysfunction in a Murine Model of Diabetic Retinopathy.

International journal of molecular sciences| PubMed ID: 32872333

2020
2020
2020
2020
2021
2021
2021
2021
2021
2021
2021
2021
Metabolism in Retinopathy of Prematurity.

Life (Basel, Switzerland)| PubMed ID: 34832995

2021
PPARα Modulation-Based Therapy in Central Nervous System Diseases.

Life (Basel, Switzerland)| PubMed ID: 34833044

2021
2021
Retinal Disease and Metabolism.

Life (Basel, Switzerland)| PubMed ID: 35207471

2022
Ocular Ischemic Syndrome and Its Related Experimental Models.

International journal of molecular sciences| PubMed ID: 35563640

2022